Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
- 14 December 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 12 (1), 287-292
- https://doi.org/10.1021/nl2035354
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune ResponseMolecular Pharmaceutics, 2010
- ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.2009
- Delivery of RNA interference therapeutics using polycation-based nanoparticlesAdvanced Drug Delivery Reviews, 2009
- KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?BMC Cancer, 2009
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the LiverMolecular Therapy, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Polymeric nanoparticles for siRNA delivery and gene silencingInternational Journal of Pharmaceutics, 2009
- Targeting the Kinesin Spindle Protein: Basic Principles and Clinical ImplicationsClinical Cancer Research, 2008
- Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery PlatformACS Nano, 2008
- Application of an HIV gp41-Derived Peptide for Enhanced Intracellular Trafficking of Synthetic Gene and siRNA Delivery VehiclesBioconjugate Chemistry, 2008